BRPI0817742A2 - Composto de amida de ácido acrílico de indazol - Google Patents

Composto de amida de ácido acrílico de indazol

Info

Publication number
BRPI0817742A2
BRPI0817742A2 BRPI0817742A BRPI0817742A2 BR PI0817742 A2 BRPI0817742 A2 BR PI0817742A2 BR PI0817742 A BRPI0817742 A BR PI0817742A BR PI0817742 A2 BRPI0817742 A2 BR PI0817742A2
Authority
BR
Brazil
Prior art keywords
indazole
acrylic acid
acid amide
amide compound
compound
Prior art date
Application number
Other languages
English (en)
Inventor
Tetsuo Yamaguchi
Hiroyuki Kawanishi
Hideki Ushirogochi
Tatsuyuki Takahashi
Tohru Takebe
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of BRPI0817742A2 publication Critical patent/BRPI0817742A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0817742 2007-09-28 2008-09-26 Composto de amida de ácido acrílico de indazol BRPI0817742A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007253463 2007-09-28
PCT/JP2008/067393 WO2009041559A1 (ja) 2007-09-28 2008-09-26 インダゾールアクリル酸アミド化合物

Publications (1)

Publication Number Publication Date
BRPI0817742A2 true BRPI0817742A2 (pt) 2015-03-31

Family

ID=40511439

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817742 BRPI0817742A2 (pt) 2007-09-28 2008-09-26 Composto de amida de ácido acrílico de indazol

Country Status (12)

Country Link
US (1) US8022059B2 (pt)
EP (1) EP2192116A4 (pt)
JP (1) JPWO2009041559A1 (pt)
KR (1) KR20100046064A (pt)
CN (1) CN101874022A (pt)
AU (1) AU2008304867B2 (pt)
BR (1) BRPI0817742A2 (pt)
CA (1) CA2700113A1 (pt)
MX (1) MX2010003393A (pt)
RU (1) RU2444515C2 (pt)
TW (1) TW200922558A (pt)
WO (1) WO2009041559A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013216579A (ja) * 2010-07-06 2013-10-24 Mitsubishi Tanabe Pharma Corp 三置換インダゾールアクリル酸アミド誘導体の製造方法
AU2011323245B2 (en) * 2010-11-05 2016-01-21 Senomyx, Inc. Compounds useful as modulators of TRPM8
WO2013103004A1 (ja) * 2012-01-05 2013-07-11 田辺三菱製薬株式会社 (2e)-3-(1h-インダゾール-3-イル)-n-(3-メトキシフェニル)-n-[3-(メチルスルホニル)プロピル]ブト-2-エンアミドの結晶形
CN105061410B (zh) * 2015-08-03 2018-04-20 江苏红豆杉药业有限公司 一种阿法替尼及其制备方法和应用
US10392371B2 (en) 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8
CN111100070A (zh) * 2018-10-26 2020-05-05 北京师范大学 一种阳离子型n-取代苯胺离子液体及其制备方法
US11660348B1 (en) 2022-02-01 2023-05-30 Akos Biosciences, Inc. Cannabinoid conjugate molecules
US11883499B2 (en) 2022-02-01 2024-01-30 Akos Biosciences, Inc. Cannabinoid conjugate molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1045716A (ja) * 1996-07-31 1998-02-17 Yamanouchi Pharmaceut Co Ltd 2,3−ジヘテロアリールアクリロイルグアニジン誘導体
AUPO545297A0 (en) * 1997-03-04 1997-03-27 Fujisawa Pharmaceutical Co., Ltd. Guanidine derivatives
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
EP1648448A4 (en) * 2003-07-29 2009-04-01 Smithkline Beecham Corp CHEMICAL COMPOUNDS
JP4050730B2 (ja) 2004-07-30 2008-02-20 株式会社東芝 酸化物超電導体およびその製造方法

Also Published As

Publication number Publication date
US8022059B2 (en) 2011-09-20
JPWO2009041559A1 (ja) 2011-01-27
US20100256108A1 (en) 2010-10-07
AU2008304867B2 (en) 2011-04-21
AU2008304867A1 (en) 2009-04-02
WO2009041559A1 (ja) 2009-04-02
MX2010003393A (es) 2010-04-09
RU2010116779A (ru) 2011-11-10
CA2700113A1 (en) 2009-04-02
EP2192116A4 (en) 2011-11-09
KR20100046064A (ko) 2010-05-04
EP2192116A1 (en) 2010-06-02
TW200922558A (en) 2009-06-01
RU2444515C2 (ru) 2012-03-10
CN101874022A (zh) 2010-10-27

Similar Documents

Publication Publication Date Title
HK1257260A1 (zh) 谷氨酸的異質二聚體
ATE478849T1 (de) 4-anilinochinolin-3-carbonsäureamide als csf-1r- kinaseinhibitoren
BRPI0912778A2 (pt) composto de amida
CY2019011I2 (el) C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης
BRPI0817742A2 (pt) Composto de amida de ácido acrílico de indazol
BR112012006686A2 (pt) composto amida substituído
DK2365754T3 (da) Herbicidsammensætninger indeholdende benzoylpyrazolforbindelser
ZA201104411B (en) Tetrazole substituted anthranilic acid amides as pesticides
IL207955A0 (en) Boron - containing small molecules as anti - inflammatory agents
EP2187893A4 (en) SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS
ATE509925T1 (de) Substituierte bicyclocarbonsäureamidverbindungen
BRPI0918602A2 (pt) composto (i)
BRPI0907963A2 (pt) Derivados de indazola
ZA201006754B (en) Crystal of benzimidazole compound
BRPI0815112A2 (pt) Derivado de aminopirazol amida
BRPI0815332A2 (pt) Composto de ácido fenilacético
BRPI0912823A2 (pt) ácido hidrociânico contendo carbono de biorecursos
BRPI0906879A2 (pt) Compostos terapêuticos
EP2345644A4 (en) INDAZOLE COMPOUND
DK2206711T3 (da) Tetomilast-polymorf
IT1396036B1 (it) Configurazione strutturale di campo cimiteriale
FI20085971A0 (fi) Betaiinin käyttö
ITFI20080186A1 (it) Miscelatore msa 206
UA18398S (uk) Комплект етикеток для горілки «русский калибр»
TH0801004753B (th) องค์ประกอบที่มีสารประกอบเซซามิน-คลาสส์ และสารประกอบแอราคิดอนิคแอซิด คลาสส์

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.